|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.92 EUR | +1.54% |
|
+1.12% | -2.84% |
| 06-10 | Bayer hopes to speed up biofuel feedstock plan amid Iran war energy crunch | RE |
| 06-10 | Bayer's Marketing Authorization Application for Asundexian Gets EU Medicines Agency's Validation | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 40.15B | |||||
| 1,013B | |||||
| 574B | |||||
| 397B | |||||
| 324B | |||||
| 280B |
- Stock Market
- Stocks
- BAYN Stock
- Charts Bayer AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition